Prostate cancer that spreads or comes back after treatment is often small and hard to detect. A new test called a PSMA PET scan makes these tumors easier to spot. Learn more.

Prostate-specific membrane antigen (PSMA) is a protein found in small amounts in your prostate gland. Learn how it can help with prostate cancer.

Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed.

PSMA PET can improve prostate cancer staging accuracy compared with conventional imaging, which has treatment implications.

An expert discusses how CT scans and bone scans remain the standard imaging approach for most patients with metastatic castration-resistant prostate cancer (mCRPC), whereas prostate-specific membrane ...

PSMA-PET scans detect metastatic disease in 46% of patients with high-risk nonmetastatic hormone-sensitive prostate cancer, revealing understaging by conventional imaging.

PSMA-PET scans of Michael Rosenblum before treatment (left) show prostate cancer metastases (small dark spots) throughout his body. After treatment (right), metastatic cancer is no longer visible.

PSMA-PET leverages ‘radiotracers’ that bind to prostate cancer cells, making them visible on PET scans and providing functional imaging that reveals the biological activity of cancer.

(UroToday.com) The 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting held in New Orleans, LA, was host to an Oncology Discovery and Translational session. Dr. Gary Ulaner ...